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Abstract
Chronic pain has been often associated with myofascial pain syndrome (MPS), which is determined 
by myofascial trigger points (MTrP). New features have been tested for MTrP diagnosis. The 
aim of this study was to evaluate two-dimensional ultrasonography (2D US) and ultrasound 
elastography (UE) images and elastograms of upper trapezius MTrP during electroacupuncture 
(EA) and acupuncture (AC) treatment. 24 women participated, aged between 20 and 40 years 
(M ± SD = 27.33 ± 5.05) with a body mass index ranging from 18.03 to 27.59 kg/m2 (22.59 ± 
3.11), a regular menstrual cycle, at least one active MTrP at both right (RTPz) and left trapezius 
(LTPz) and local or referred pain for up to six months. Subjects were randomized into EA and 
AC treatment groups and the control sham AC (SHAM) group. Intensity of pain was assessed 
by visual analogue scale; MTrP mean area and strain ratio (SR) by 2D US and UE. A significant 
decrease of intensity in general, RTPz, and LTPz pain was observed in the EA group (p = 0.027; 
p < 0.001; p = 0.005, respectively) and in general pain in the AC group (p < 0.001). Decreased 
MTrP area in RTPz and LTPz were observed in AC (p < 0.001) and EA groups (RTPz, p = 
0.003; LTPz, p = 0.005). Post-treatment SR in RTPz and LTPz was lower than pre-treatment in 
both treatment groups. 2D US and UE effectively characterized MTrP and surrounding tissue, 
pointing to the possibility of objective confirmation of subjective EA and AC treatment effects.
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Introduction
Myofascial pain syndrome (MPS) is an important musculoskeletal (MSK) dysfunction1,2 
described as a regional myogenic disorder usually accompanied by local or referred pain, 
decreased range of motion, weakness, autonomic phenomena, local allodynia, and hyperalgesia 
in referred pain areas.3,4 The reported prevalence of MPS in the general population reaches up to 
85%.5 MPS is associated with many pain conditions, including temporomandibular joint disor-
ders, tension-type headache, migraine, spine disorders, and neck and shoulder pain.6,7 As MPS is 
often associated with other pathologies, and due to the lack of standardization regarding assess-
ment and diagnosis, the natural history of MPS remains incompletely understood.8,9
Travell and Simons first systematically described MPS10 and reported the presence of hyper-
sensitive spots within taut bands of skeletal muscle fibers or fascia, known as myofascial trigger 
points (MTrP), as the main characteristic of MPS.5,11 MTrP are classified as active or latent, 
depending in part on the recognition of pain, either spontaneous or reproduced by palpation, as 
familiar for the patient. MTrP associated with painful sensations as part of the clinical complaints 
are considered active MTrP, while those without pain are latent MTrP.2,5
Although indicated as the main diagnostic tool for MTrP assessment, manual palpation can 
show conflicting results in regard to reliability and repeatability as the clinical skill and experi-
ence of the examiner can influence outcome.12,13 Better results are shown in evaluation of the 
upper trapezius, which is frequently involved with neck pain and chronic tension-type headache 
due to the high incidence of MTrP.14,15
Recent advances in technology have characterized the physical and biochemical nature of the 
taut bands of skeletal muscle fibers and MTrP by imaging techniques such as ultrasonography 
(US), magnetic resonance elastography (MRE), sonoelastography (SE), and ultrasound elastog-
raphy (UE).12,16-18 These studies showed increased taut band rigidity in MRE images, reduced 
vibration amplitude of affected tissue by SE, changes in blood vessel systolic and diastolic veloc-
ities near MTrP by color Doppler US, and focal hypoechoic areas with heterogeneous echotex-
ture for MTrP by two-dimensional US (2D US). In addition, there are reports of guided MTrP 
anesthetic injections applied directly at hypoechoic areas assessed by 2D US.19,20
UE has the potential to characterize the viscoelastic properties of the tissue, allowing objec-
tive MTrP identification due to greater tissue stiffness.17,21,22 Elasticity variations might be 
observed as color variance in elastograms.23 Some equipment allows estimation of the strain ratio 
(SR) between two regions of interest (ROI), enabling quantification of image findings and pro-
viding reference values, such as in breast differential diagnosis.24 Only few studies thus far have 
assessed MSK using UE.25
Acupuncture (AC) and electroacupuncture (EA), a form of acupuncture in which an electrical 
current is applied to acupuncture needles,11 have both been used as alternatives to conventional 
treatments for MSK pain.26,27 Melzack et al.28 and Kao et al.29 reported a correlation between 
MTrP and AC points by comparison of their spatial distribution, referred pain, and electrophysi-
ological behavior, supporting the application of these acupuncture techniques in MPS treatment. 
Although AC and EA have been shown to be effective in chronic pain treatment,30-32 whether one 
of these treatments is more effective than the other has not been examined.
Thus, the aim of this study was to evaluate 2D US and UE imaging and elastograms to deter-
mine the effectiveness of EA and AC treatment of MTrP in women presenting myofascial pain in 
the upper trapezius and verify the therapeutic effect on pain intensity.
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Materials and Method
Design
A double-blinded randomized, controlled, pilot study was conducted between January and 
August 2013 at the Electromyography and Ultrasonography Laboratory of the Department of 
Pediatric Dentistry, Piracicaba Dental School, University of Campinas, Piracicaba, Sao Paulo, 
Brazil, as part of the base research “Evaluation of acupuncture and electroacupuncture in the 
treatment of myofascial pain of upper trapezius muscle—A double-blinded, randomized, placebo 
controlled trial” (Sao Paulo Research Foundation—FAPESP 2011/12659-1). The Research 
Ethical Committee of the Piracicaba Dental School approved the project (Protocol Number 
003/2011). The volunteers were asked to read and sign the consent form and were informed about 
the procedures, discomfort and/or risks, benefits of the research, and the need to attend all ses-
sions. The Brazilian Clinical Trials Registry number is RBR-42kz9z (available at http://www.
ensaiosclinicos.gov.br/rg/RBR-42kz9z/).
Study Population
Through local posters, the institutional web page, and personal invitations, responses were solic-
ited from females aged between 18 and 40 years with complaints of pain in the head, neck, and/
or upper back for six months or more. These criteria were focused on women of reproductive age 
to allow menstrual cycle monitoring during the study, as it may influence occurrence and inten-
sity of pain as well as nociception.33 The following inclusion and exclusion criteria were applied:
Inclusion criteria: age range from 18 to 40 years, body mass index (BMI) between 18 and 29.9 
kg/m2 (considering normal range and overweight categories from World Health Organization—
WHO Global Database on Body Mass Index; for more details, please see http://apps.who.int/
bmi/index.jsp?introPage=intro_3.html), regular menstrual cycle (using oral contraceptives or 
not using contraceptives), and one or more active MTrP in both right and left upper trapezius 
(RTPz and LTPz, respectively) associated with local and/or referred pain for six months or 
more.
Exclusion criteria: fibromyalgia, cervical radiculopathy, systemic diseases, use of cardiac 
pacemaker or electronic implants, daily administration of headache and muscular pain medi-
cation, physical therapeutic interventions for myofascial pain within the month prior to the 
study, and pregnancy, all informed by the volunteers. Evident cognitive impairment or com-
munication difficulties and accentuated postural abnormalities were also evaluated by the 
examiner (C.E.E.M.) at the first meeting.
A convenience sample of 32 women who were participating in the above-cited research was 
selected. Ages ranged from 20 to 40 years (M ± SD = 27.44 ± 5.23) and the BMI from 18.03 to 
27.59 kg/m2 (22.54 ± 2.88). The women were randomly distributed into three groups, EA and AC 
treatment groups, and a control group treated with sham AC (SHAM). The menstrual cycle phase 
was recorded, and the use of oral contraceptives was indicated as follows: paused oral contracep-
tion (POC), continuous oral contraception (COC), and without oral contraception (WOC). 
Randomization for inclusion in each treatment group was performed using the Microsoft Excel 
random function. Participants and the examiner were blinded to treatment groups. Five volunteers 
discontinued the intervention due to lack of time (EA, n = 1; AC, n = 1; SHAM, n = 3). Due to 
problems in data collection, such as the inability to adequately reproduce the transducer compres-
sions in UE, three volunteers were excluded (EA, n = 1; AC, n = 2). Thus, the final sample was 
composed of 24 volunteers (M ± SD, age 27.33 ± 5.05 years and BMI 22.59 ± 3.11) (Figure 1).
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Procedures
Myofascial trigger point diagnosis. The diagnosis of MTrP was performed at the first meeting dur-
ing a physical examination by a blind examiner (C.E.E.M., a physical therapist with high exper-
tise in MPS diagnosis and management).
During the MTrP evaluation, the volunteer remained seated comfortably in a chair with adjust-
able height, with feet flat on the floor, knees at 90 degrees and forearms resting on the lower 
limbs. Palpation protocol was conducted according to the following steps:
1. Palpation over the upper trapezius muscle to identify taut bands and their extension.
2. Gentle compression of painful spots along taut bands to elicit pain and precisely localize 
tender spots with the aid of verbal information from the subject concerning painful 
sensations.
3. Sustained compression up to approximately 6 s, depending on individual sensitivity, to 
elicit pain and confirm referred pain occurrence.
MTrP diagnosis was based on the following five criteria:1,2,5
1. Localization of a palpable taut band within skeletal muscle.
2. Hypersensitive tender spot within taut bands.
3. Local twitch response elicited by the snapping palpation of the taut band.
4. Reproduction of the typical referred pain pattern of the MTrP in response to 
compression.
5. Recognition of pain patterns as familiar.
Furthermore, MTrP were considered active if referred pain, whether spontaneous or evoked 
by compression, reproduced patient clinical complaint. If the referred pain did not reproduce a 
familiar pain, MTrP were considered latent.
Figure 1. Study flow chart. AC = acupuncture; EA = electroacupuncture.
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Sessions and instrumentation. Eight treatment sessions were scheduled at the same time of the day 
over 24 to 26 days, with two sessions each week with a duration of 30 min each.31 The selected 
acupuncture points included the gallbladder meridian 20 (GB20), gallbladder meridian 21 
(GB21), large intestine four (LI4), liver meridian three (LV3),34 and up to two Ashi points in each 
upper trapezius, described as painful points not predicted on meridians and not necessarily coin-
cident with MTrP, although sometimes coinciding.
Stainless steel, individually wrapped, sterilized, disposable needles (0.25 mm diameter × 30 
mm length) were used for treatments (Dong-Bang, Korea). For the EA group, treatments were 
administered with the EL608 electrical stimulation equipment (NKL, Brazil; ANVISA 
80191680002), with microprocessed stimulus generation and control, eight isolated outputs 
through pulse transformers, and yielding asymmetrical biphasic unpolarized waveforms. The 
equipment was connected to needles inserted in the AC points GB20 and GB21 and in two more 
Ashi points in each TPz. The frequency was set to alternate between 2Hz (700 µs width, T1 = 5 
s) and 100Hz (500 µs width, T2 = 5 s), with a 30 min total treatment. The current intensity was 
adjusted for the maximum painless stimuli and increased in a gradual manner until a muscle 
contraction was observed.32,35 In the SHAM group, needles were inserted superficially 1 cm from 
the correct AC points36 for the same treatment time as the other groups. The treatments were 
performed by a physical therapist (M.F.M.A.) specialized in AC.
Evaluations. All evaluations were performed by the same examiner, who had completed one year 
of training and practice for US and UE techniques (C.E.E.M.), and who was blinded for the treat-
ment type. Pre- and post-treatment evaluations were fixed between the second and fifth men-
strual period days according to Greenspan et al.,33 with an interval ranging from 28 to 30 days, 
so that the initial and post-treatment evaluations were performed in the same period of the men-
strual cycle. Post-treatment evaluation was conducted two to five days after the last session.
Pain intensity. Local pain intensity in the RTPz and LTPz, as well as pain in head, neck, and/
or upper back (general pain), was quantified using a visual analogue scale (VAS). The VAS 
consisted of an unanchored horizontal line 10 cm in length, with the left end corresponding to 0 
(no pain) and the right end corresponding to 10 (maximum pain). Volunteers were asked to mark 
their pain intensity on the scale. Afterward, the marked location was measured with a ruler by 
the blinded examiner.
Two-dimensional ultrasound and ultrasound elastography. MTrP in the upper trapezius were 
evaluated bilaterally through US and UE images at pre- and post-treatment.
The 2D US and UE images and elastograms were acquired using a digital SSA-780A-APLIO 
MX US (Toshiba Medical Systems Corporation, Japan) equipment with 7 MHz to 18 MHz linear 
array transducer (38 mm) and Elasto-Q (Toshiba Medical Systems Corporation, Europe) soft-
ware. For image adjustment, power, intensity, and edge enhancement were established before 
data collection and remained the same for all pre- and post-treatment examinations. The one-
touch Quickscan function was used once per exam, which automatically optimizes 2D US gain 
level, improving image quality with acoustic precision, while suppressing white noise in echo-
weak regions. No manual adjustment of the parameters was performed. Foci placement was also 
established before data collection and remained the same for all analyses. Next, the volunteer’s 
skin was marked halfway between the seventh cervical vertebra and the tip of the acromion with 
a pen to guide muscle examination. The blinded examiner performed the exam targeting the 
transducer at resting LTPz and RTPz, longitudinal to the muscle fascicles, looking for focal 
hypoechoic areas with heterogeneous echotexture images, which is consistent with presence of 
MTrP (Figure 2). As all volunteers had active MTrP in both TPz at the point marked on the skin, 
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or very close to it, the central region of the transducer was always kept over the marked point. 
The most central MTrP on the pre-treatment images was considered for analysis if more than one 
MTrP were observed at the same sight. Image J, version 1.45 (National Institutes of Health, 
U.S.), and the ROI standard measurement tool provided with the software were used to assess 
MTrP area on 2D US images manually outlined (Figures 3 and 4). Measurements were deter-
mined at pre- and post-treatment, and the mean value was used for statistical analysis. The 
respective images were randomized concerning the treatment groups and observed together to 
distingue the anatomic structures and the pattern of muscular tissue providing the confirmation 
for the examiner if the measurements were performed in the same MTrP. K-PACS software, ver-
sion 1.6.0 (DICOM Viewing Software, Germany), was used to convert 2D US DICOM format 
images to JPEG, which could be analyzed with Image J.
The second step was to perform the UE exam. With the transducer placed over the marked 
skin, the examiner performed 6 to 10 rhythmically cadenced maneuvers of the transducer over 
the muscle, following the equipment guidelines for standardization of the technique by tissue 
compression and decompression sinusoid visualization. The elastograms were then generated 
using Elasto-Q, which records and enables 2D US and elastogram images for the same sight and 
provides tools that allow switching between them to verify whether hypoechoic points coincide 
with the points of increased tissue stiffness. Next, as described in Figure 5, after localization of 
the best sinusoid compression, two ROI were selected for the SR measurement, considering the 
mean strain of each ROI. The first point was selected as a reference point in an unaffected and 
normal region of muscle. The second point indicated tissue with MTrP. This study followed the 
approach in the previous breast study, in which two ROI are placed at the same tissue depth to 
minimize possible differences in tissue compression responses due to different depth localiza-
tion. ROI size was the same for all subjects and for reference and pathological sites. The greatest 
possible uniformity of color in ROI selection was observed for both reference (green) and patho-
logical (blue) points.
Statistics. For statistical analysis of pain intensity (general and localized in both TPz), MTrP 
mean area and SR, the SigmaPlot version 11.0 (Systat Software, Canada) was used. The 
assumptions of equality of variances and normal distribution of errors were checked for all 
variables (Shapiro–Wilk test). To identify homogeneity between the groups in pre-and post-
treatment, one-way ANOVA or Kruskal–Wallis test were applied depending on data distribu-
tion. Student’s paired t test was applied in pre- and post-treatment data, as all data had normal 
distribution.
Results
Sample Characteristics and Chronic Pain Characterization
Participants from all three groups (n = 24) reported a history of pain of 6.85 ± 4.61 years (M ± 
SD), with a frequency of 5.50 ± 2.06 times per week. All subjects reported muscular pain in the 
upper back at both RTPz and LTPz. On closer examination of different regions of the head, 
33.3% of the sample (n = 8) indicated frontal pain, 54.2% (n = 13) temporal, 16.6% (n = 4) pari-
etal, and 50.0% (n = 12) pain in occiput. A total of 79.2% (n = 19) also reported cervicalgia, and 
33.3% (n = 8) reported migraine. Oral contraceptive use was as follows: WOC 25.0% (n = 6), 
POC 54.2% (n = 13), and COC 20.8% (n = 5). Contraceptive use was randomly distributed 
among the treatment groups. More information on sample characteristics and group distribution 
can be seen in Table 1.
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Figure 2. 2D US images from the same volunteer before and after treatment. Before treatment, normal 
linear fascicular pattern appeared shapeless, discontinuous, undulated and brighter than after treatment. 
LTPz = left upper trapezius; MTrP = myofascial trigger points.
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Figure 3. The arrows indicate the hypoechoic region to be outlined. TE = left upper trapezius.
Figure 4. Example of the MTrP area ROI. MTrP = myofascial trigger points; ROI = regions of interest; 
TPz = trapezius; TE = left upper trapezius.
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Pain Intensity
Results from the pre- and the post-treatment analyses are shown in Table 2. During pre-treatment, 
no differences were found among groups regarding general pain (p = 0.242) and RTPz and LTPz 
pain (p = 0.876 and p = 0.380, respectively, ANOVA). Notably, a decrease of intensity in general, 
RTPz, and LTPz pain was observed in the EA group and a decrease in general pain in the AC 
group. No statistically significant results were found in the SHAM group. Moreover, inter-group 
analysis did not show differences (p > 0.05).
Two-Dimensional Ultrasound
Pre- and post-treatment results are shown in Table 3. MTrP areas were similar among groups before 
treatment (RTPz, p = 0.294, Kruskal–Wallis; LTPz, p = 0.679, ANOVA). After treatment, 
Figure 5. UE of the TPz assessed with Elasto-Q function, which allowed SR measurement. The 
selection of two ROIs can be observed in the elastogram, in which the color scale indicates elasticity 
of tissue. Blue indicates lower elasticity, green refers to intermediate elasticity, and red indicates 
high elasticity and healthy muscle tissue. Immediately below the elastogram, the compression and 
decompression tissue sinusoid that aided in the standardization of the transducer maneuvers can be 
observed. In way to SR calculation within collected data, a point at the peak of the best compression 
sinusoid was selected. ROI 1 and 2 were placed such that ROI 1 corresponded to a reference point in 
the muscle, presumably without MTrP, and ROI 2 corresponded to a region potentially including MTrP. 
On the right side of the image, white arrows point to ROI 1 and ROI 2 graphic consisted by tissue strain 
data for the selected scan time. As predicted, lower values were observed for ROI 2 (MTrP location), 
consistent with the presumed lower local elasticity from MTrP physiopathology. UE = ultrasound 
elastography; TPz = trapezius; SR = strain ratio; ROI = regions of interest; MTrP = myofascial trigger 
points.
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significantly lower MTrP area was observed in the EA and AC groups, with nonstatistically signifi-
cant results in the SHAM group. Inter-group analysis did not show differences (p > 0.05, ANOVA).
Ultrasound Elastography
The results for each group are shown in Table 4. There were no differences in SR among groups 
for RTPz (p = 0.230) and LTPz (p = 0.089) (Kruskal–Wallis) before treatment. A decrease in SR 
post treatment was observed in the EA and AC groups, although without statistical significance. 
The SHAM group results suggest an increase of SR post treatment. Inter-group comparisons did 
not show any differences (p > 0.05).
Discussion
Pain Intensity
EA treatment results showed decreased general and local pain intensity, while only general pain 
was decreased in the AC group. Thus, the analgesic effect of transcutaneous electrical acupoint 
Table 1. Sample Characteristics, Oral Contraceptive Use Distribution, Chronic Pain Characterization, 
and Body Pain Locations of the Three Treatment Groups.
EA Group (n = 7)
AC Group  
(n = 9)
SHAM Group  
(n = 8)
Sample Characteristics M ± SD M ± SD M ± SD
Age (years) 30.00 ± 4.80 26.33 ± 3.81 26.13 ± 6.13
BMI (kg/m2) 23.19 ± 3.70 21.19 ± 2.80 23.63 ± 2.64
Oral Contraceptive Use n % n % n %
WOC 2 28.6 2 22.2 2 25.0
POC 4 57.1 5 55.6 4 50.0
COC 1 14.3 2 22.2 2 25.0
Chronic Pain Characterization M ± SD M ± SD M ± SD
Duration (years) 7.64 ± 5.01 6.11 ± 5.11 7.00 ± 4.14
Frequency (times/week) 5.00 ± 2.20 6.14 ± 1.57 5.00 ± 2.20
Body Pain Locations n % n % n %
Head
 Frontal 2 28.6 2 22.2 4 50.0
 Temporal 1 14.3 8 88.9 4 50.0
 Parietal 0 0 3 33.3 1 12.5
 Occipital 2 28.6 5 55.6 5 62.5
Neck 4 57.1 9 100.0 6 75.0
Upper back
 RTPz 7 100.0 9 100.0 8 100.0
 LTPz 7 100.0 9 100.0 8 100.0
Migraine 3 42.9 3 33.3 2 25.0
EA = electroacupuncture; AC = acupuncture; BMI = body mass index; WOC = without oral contraception; POC = 
paused oral contraception; COC = continuous oral contraception; RTPz = right trapezius; LTPz = left trapezius.
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Table 2. Intra- and Inter-group Comparisons of General Pain Intensity (Head, Neck, and/or Upper 
Back) and Local RTPz and LTPz Pain Pre- and Post-treatment.
Treatment Group Pain
VAS Pre-treatment 
(cm) M ± SD
VAS Post-treatment 
(cm) M ± SD pa
EA (n = 7) General 6.86 ± 1.05 2.91 ± 2.95 0.027
RTPz 5.16 ± 1.26 1.50 ± 1.24 <0.001
LTPz 4.90 ± 2.46 1.50 ± 1.78 0.005
AC (n = 9) General 6.03 ± 1.31 3.14 v 1.76 <0.001
RTPz 5.07 ± 2.22 3.59 ± 2.02 0.118
LTPz 3.02 ± 2.83 2.61 ± 2.20 0.603
SHAM (n = 8) General 5.60 ± 1.75 4.78 ± 2.37 0.296
RTPz 4.65 ± 2.43 3.41 ± 2.52 0.052
LTPz 4.10 ± 2.60 3.03 ± 2.06 0.198
Inter-group comparisons in pre- and post-treatment, ANOVA, p > 0.05. RTPz = right trapezius; LTPz = left trapezius; 
VAS = visual analogue scale; EA = electroacupuncture; AC = acupuncture.
aStudent’s paired t test.
Table 3. Intra- and Inter-group Comparisons of MTrP Areas Pre- and Post-treatment (Pixels).
Treatment Group Muscle
Pre-treatment 
(Pixels) M ± SD
Post-treatment 
(Pixels) M ± SD pa
EA (n = 7) RTPz 1911.86 ± 499.21 1252.00 ± 330.46 0.003
LTPz 1761.14 ± 613.09 1324.64 ± 620.61 0.005
AC (n = 9) RTPz 1693.56 ± 617.52 1070.22 ± 411.28 <0.001
LTPz 1553.11 ± 477.08 1054.61 ± 400.22 <0.001
SHAM (n = 8) RTPz 1520.06 ± 312.61 1397.75 ± 253.90 0.117
LTPz 1549.75 ± 496.98 1396.25 ± 362.70 0.093
Inter-group comparisons in pre- and post-treatment, ANOVA, p > 0.05. MTrP = myofascial trigger points; EA = 
electroacupuncture; RTPz = right trapezius; LTPz = left trapezius; AC = acupuncture.
aStudent’s paired t test.
Table 4. Intra- and Inter-group Comparisons of SR for RTPz and LTPz Pre- and Post-treatment.
Treatment 
Group Muscle Pre-treatment SR Post-treatment SR pa Difference
EA (n = 7) RTPz 3.69 ± 2.80 2.20 ± 0.96 0.104 1.49 ± 2.06
LTPz 2.98 ± 1.64 2.74 ± 1.17 0.740 0.23 ± 1.76
AC (n = 9) RTPz 3.14 ± 1.15 2.46 ± 0.52 0.216 0.68 ± 1.53
LTPz 3.84 ± 1.51 2.63 ± 0.95 0.065 1.21 ± 1.70
SHAM (n = 8) RTPz 2.19 ± 1.01 2.67 ± 0.76 0.159 −0.48 ± 0.87
LTPz 2.39 ± 1.09 2.56 ± 1.21 0.678 −0.17 ± 1.08
Inter-group comparisons in pre- and post-treatment, ANOVA, P > 0.05. SR = strain ratio; RTPz = right trapezius; 
LTPz = left trapezius; EA = electroacupuncture; AC = acupuncture.
aStudent’s paired t test.
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stimulation, which differs from current EA methodology only by the presence of a transcutane-
ous electrode instead of the needle, is demonstrated.37 These results suggest that electrical anal-
gesic stimulation added to the needle stimulation effects at AC points presented better results for 
local pain than general pain.
Literature comparing EA and AC therapeutic effects on myofascial pain is scarce. Aranha 
et al.32 reported a decrease in the intensity of chronic myofascial pain in women treated by EA, 
which is consistent with the findings of this study. Zheng et al.30 observed that EA efficacy 
reduced opioid-like medication, decreased pain intensity, and increased the pressure pain thresh-
old in women with chronic myofascial pain at the upper trapezius after eight EA sessions. As the 
SHAM group showed nonstatistically significant improvement, higher EA and AC efficiency in 
the treatment of myofascial pain of the upper trapezius muscle after eight treatment sessions can 
be suggested.
Two-Dimensional Ultrasound
Through the development of new technologies, US diagnosis of myofascial tissue is now consid-
ered the most reliable approach and has been indicated as a method of quantifying grayscale 
variation findings to confirm results of different treatments. MSK system diseases may appear in 
2D US images as grayscale variations due to changes of soft tissue mechanical properties. The 
subjective image analysis of the present study showed grayscale degree and pattern changes in 
MTrP areas as focal hypoechoic and heterogeneous echotexture regions, consistent with other 
studies.17,20 Conversely, Lewis and Tehan38 reported unsuccessful MTrP US image diagnosis, 
which is likely due to technical limitations at the time of study.
The findings showing decreased MTrP areas after treatment of both RTPz and LTPz suggest that 
EA and AC improved local microvascularization, demonstrating better therapeutic effects on the 
inflammatory process than the SHAM group, which did not show significant results. The energy 
crisis theory5 has been proposed to explain the formation of MTrP as a result of intense contraction 
of muscle fibers and consequent local hypoxia. In accordance with Shah et al.,39 2D US hypoechoic 
findings correspond to those characteristics, corroborating the energy crisis theory.5
From subjective observation of 2D US in this study, brighter lines were observed within mus-
cle fascicules on dysfunctional tissue and appeared to be softer and better organized in healthy 
tissue. This may be related with increased thickness of myofascial tissue and connective tissue 
involved in MTrP.
Stecco et al.40 evaluated the thickness of sternocleidomastoid and scalene muscle fascia and 
demonstrated a statistically significant decrease in average density of fascia in subjects with 
chronic neck pain after treatment. Langevin et al.41 accessed thoracolumbar fascia in individuals 
with chronic low back pain and demonstrated greater thickness due to the involvement of the 
myofascial tissue in MPS.
Concerning the characterization of taut bands by 2D US images (which is different from 
evaluating just the MTrP area), irregular muscle fascicles were observed in affected tissue, in 
which the normal linear fascicular pattern appeared discontinuous, wavy, or clumped at the taut 
band.42 These reported tissue conditions seem to be consistent with the subjective observation of 
the fascia in this study.
Further studies are necessary to expand proper interpretation of these results.
Ultrasound Elastography
In elastograms, changes in tissue viscoelastic properties are observed by color scale variations. 
In addition, the SR can be calculated with the aid of specific software available with the US 
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equipment and has been used in MTrP evaluation in the literature. UE has been well researched 
and used for breast differential diagnosis, and was even suggested as a benchmark for benign and 
malignant nodule identification.24
Concerning a different elasticity imaging technique associated with US, Langevin et al.43 
accessed thoracolumbar fascia by shear wave elastography in individuals with chronic low back 
pain and demonstrated reduced shear strain values in the experimental group compared with 
control healthy subjects. The authors also reported significant correlations between thoracolum-
bar fascia shear strain and perimuscular connective tissue thickness, which was greater in chronic 
low back pain subjects.
Although nonstatistically significant values were found for post-treatment SR in the EA and 
AC groups, the results suggest a possible improvement of tissue conditions, with lower post-
treatment SR values in both treatment groups. In comparison, the SHAM group presented the 
opposite results, showing higher SR post-treatment values, suggesting increased tissue stiffness 
of MTrP areas compared with its surrounding tissue.
Study Limitations
This study contributes to the development of objective MPS and MTrP evaluation, enabling a 
better understanding of the natural history and appropriate evaluation and monitoring of patients 
with chronic myofascial pain. However, several study limitations should be considered. First, 
this study is exploratory and descriptive, and findings are from a small convenience sample. 
Thus, further studies with a larger representative number of subjects must be performed.
In addition, some technical difficulties must be addressed. One issue regards the technique of 
the examiner during the 2D US and UE image capture, during which the amount of pressure, 
transducer positioning over the muscle, and rhythmically cadenced maneuvers are difficult to 
control. A second issue relates to the MTrP area assessment, in which images pre- and post-
treatment were displayed at the same time for area quantification, allowing the examiner to 
observe anatomical structures and fascia features to help MTrP localization. Images were dis-
played simultaneously, as localization would be difficult to confirm in evaluation of indepen-
dently displayed images. Consequently, as this is a pilot study, the accuracy and reproducibility 
of the MTrP area and SR must be verified in further studies. Furthermore, to eliminate possible 
examiner bias, individual evaluation of the images should be considered, as well as to fix a pixel/
mm scale in the software.
As taut bands and whole muscle stiffness can improve with treatment, promoting better mus-
cle functioning and general conditions in addition to local benefits, healthy tissue selected at the 
same depth in elastograms for the SR appraisal may mask results. Thus, according to the recent 
study by Ariji et al.,21 reference points outside the target tissue should be considered in further 
studies, such as subcutaneous adipose tissue as a reference for improvement of muscular stiffness 
post treatment. However, Fischer et al.44 noted the selective results from examiner interpretation 
due to the pressure distribution dependence on the tissue depth as the major bias of compression 
elastography, which guided the experimental design of this study.
To the best of our knowledge, no previous studies have assessed the dimensions of MTrP and 
UE SR pre- and post-treatment. As MPS and MTrP diagnoses remain unclear and lack a gold 
standard,12,40 further studies are necessary to better define and quantify morphological differ-
ences between normal and dysfunctional muscle tissue with MTrP and to confirm the possibility 
of the application of 2D US and UE imaging technique in MPS and MTrP diagnosis and treat-
ment monitoring. In conclusion, our pilot study supports sample size calculation and new experi-
mental studies to improve methodological tissue evaluation, providing accuracy, sensitivity, and 
reproducibility of the SR measures and validation of the technique.
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Conclusion
The present study demonstrated the effectiveness of EA and AC in treatment of upper trapezius 
myofascial pain, and suggested that EA exhibited the most effective results in local analgesia. 
Improvement of tissue conditions was observed post-treatment for EA and AC, suggesting the 
possibility of subjective confirmation and quantification of treatment effects using 2D US images. 
UE showed no significant post-treatment results. However, the trend of decreased post-treatment 
SR values for EA and AC groups, compared with increased values in the SHAM group, suggests 
its potential in MTrP and myofascial tissue characterization.
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